We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
-6.34%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$57.8B
AUM Growth
-$2.88B
Cap. Flow
+$1.24B
Cap. Flow %
2.14%
Top 10 Hldgs %
45.42%
Holding
2,491
New
223
Increased
1,138
Reduced
765
Closed
178

Sector Composition

Rank Sector Weight
1 Technology 4.36%
2 Financials 2.9%
3 Consumer Discretionary 1.73%
4 Healthcare 1.64%
5 Consumer Staples 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCHP icon
451
Microchip Technology
MCHP
$42.8B
$4.79M 0.01%
78,478
+1,966
+3% +$129K
IBB icon
452
iShares Biotechnology ETF
IBB
$9.31B
$4.77M 0.01%
40,752
-26,744
-40% -$3.32M
IBTE
453
DELISTED
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
$4.73M 0.01%
197,534
+176,579
+843% +$4.28M
CMG icon
454
Chipotle Mexican Grill
CMG
$40.8B
$4.72M 0.01%
157,050
+8,750
+6% +$271K
FVAL icon
455
Fidelity Value Factor ETF
FVAL
$1.28B
$4.72M 0.01%
117,935
-9,056
-7% -$404K
GGG icon
456
Graco
GGG
$12.9B
$4.71M 0.01%
78,516
+12,744
+19% +$818K
WPC icon
457
W.P. Carey
WPC
$17.1B
$4.7M 0.01%
68,669
+20,414
+42% +$1.67M
ZTS icon
458
Zoetis
ZTS
$31.6B
$4.69M 0.01%
31,619
-1,624
-5% -$271K
CAG icon
459
Conagra Brands
CAG
$7.07B
$4.68M 0.01%
143,410
+2,636
+2% +$90.5K
COR icon
460
Cencora
COR
$60.3B
$4.68M 0.01%
34,552
+1,359
+4% +$195K
ALL icon
461
Allstate
ALL
$66.9B
$4.64M 0.01%
37,297
-412
-1% -$51.2K
GSK icon
462
GSK
GSK
$103B
$4.59M 0.01%
155,919
+2,833
+2% +$107K
PPG icon
463
PPG Industries
PPG
$25.9B
$4.52M 0.01%
40,855
+1,216
+3% +$150K
ARCC icon
464
Ares Capital
ARCC
$13.5B
$4.48M 0.01%
265,247
-1,151
-0.4% -$22.3K
CNI icon
465
Canadian National Railway
CNI
$78.5B
$4.45M 0.01%
41,238
+2,804
+7% +$334K
ADM icon
466
Archer Daniels Midland
ADM
$41.4B
$4.42M 0.01%
54,978
+4,128
+8% +$340K
HLNE icon
467
Hamilton Lane
HLNE
$3.63B
$4.35M 0.01%
73,004
-617
-0.8% -$43.6K
HCA icon
468
HCA Healthcare
HCA
$84.8B
$4.34M 0.01%
23,612
-513
-2% -$102K
IXUS icon
469
iShares Core MSCI Total International Stock ETF
IXUS
$57.5B
$4.33M 0.01%
84,942
-15,259
-15% -$865K
TM icon
470
Toyota
TM
$210B
$4.3M 0.01%
33,004
+393
+1% +$59.6K
IDXX icon
471
Idexx Laboratories
IDXX
$42.9B
$4.27M 0.01%
13,104
-379
-3% -$139K
BKLC icon
472
BNY Mellon US Large Cap Core Equity ETF
BKLC
$1.79B
$4.25M 0.01%
191,733
-1,514,289
-89% -$37.1M
ICLN icon
473
iShares Global Clean Energy ETF
ICLN
$2.38B
$4.24M 0.01%
221,949
-4,649
-2% -$99.1K
SNPS icon
474
Synopsys
SNPS
$71.5B
$4.23M 0.01%
13,836
-92
-0.7% -$31.1K
DFAX icon
475
Dimensional World ex US Core Equity 2 ETF
DFAX
$11.8B
$4.22M 0.01%
223,662
+1,524
+0.7% +$32.4K

Similar funds

Creative Planning's Q3 2022 Portfolio in Review

As of Q3 2022, Creative Planning held 2,491 positions worth $57.8B, down 4.8% from $60.7B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Creative Planning's Q3 2022 filing shows 223 new, 1,138 increased, 765 reduced and 178 closed positions. Its largest new stake was Greenlane Holdings: 4 shares worth $4.19M. The largest sale was iShares Core S&P 500 ETF, an estimated $168M.

By sector, the portfolio is most concentrated in Technology at 4.4% of assets, down from 4.5% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Creative Planning's largest Q3 2022 buy was Greenlane Holdings: 4 shares worth $4.19M.
  • Creative Planning added most to Schwab US Large- Cap ETF in Q3 2022, an estimated $445M increase.
  • Creative Planning's biggest Q3 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $168M.
  • Creative Planning fully exited BNY Mellon US Small Cap Core Equity ETF in Q3 2022, selling an estimated $16.3M.
  • Creative Planning's ten largest holdings make up 45% of its $57.8B portfolio in Q3 2022.
  • Creative Planning opened 223 new positions and closed 178 in Q3 2022.
  • Creative Planning's portfolio value fell 4.8% quarter-over-quarter to $57.8B.

Based on Creative Planning's 13F filing for Q3 2022, filed 3 Nov 2022.